Many studies have shown that the downregulation of ERK signaling could inhibit cell proliferation, and the activation of JNK signaling promotes apoptotic cell death [65,66,67]; however, we did not observe the regulatory effects of GeXIVA[1,2] on both ERK and JNK signaling in 4T1 tumor cells. The gene discussed is MAPK8; the disease is neoplasm.